Literature DB >> 31445380

Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study.

Ali A Weinstein1, J Michael Estep2, Leyla de Avila2, Michael Curry3, Pegah Golabi2, Carey Escheik2, Aybike Birerdinc2, Maria Stepanova4, Jillian K Price2, Lynn Gerber5, Zobair M Younossi6.   

Abstract

An important extrahepatic consequence of Hepatitis C is its adverse impact on the central nervous system and cognitive performance. We aimed to determine whether there is a significant relationship between selected neurotransmitters and cytokines and cognitive performance in patients with Chronic Hepatitis C before and after achieving sustained virologic response (SVR). Pre-SVR, elevated kynurenine was associated with increased immediate and delayed visual memory, whereas post-SVR the positive associations are between kynurenine and immediate and delayed verbal memory. TGF-B was consistently negatively associated with both immediate and delayed visual memory pre- and post-SVR. These concomitant changes may have important clinical relevance.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cognitive performance; Cytokines; Executive function; Hepatitis C; Memory

Mesh:

Substances:

Year:  2019        PMID: 31445380     DOI: 10.1016/j.jneuroim.2019.577022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations.

Authors:  Matteo Tagliapietra; Salvatore Monaco
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

Review 2.  Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?

Authors:  Mary Ew Collier; Shaowei Zhang; Nigel S Scrutton; Flaviano Giorgini
Journal:  Drug Discov Today       Date:  2021-02-18       Impact factor: 7.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.